SV
Sivaramakrishnan Venkatabalasubramanian
SRM Institute of Science and Technology, SRM Institute of Science and Technology (Deemed to be University), University of Gothenburg, University of Madras - Guindy Campus, SASTRA University
Employment
-
SRM Institute of Science and Technology Associate Professor2025 - Present
-
SRM Institute of Science and Technology (Deemed to be University) Assistant Professor (Selection Grade)2017 - 2025
-
SASTRA University Assistant Professor - Research2011 - 2017
-
University of Madras - Guindy Campus Guest Faculty/ Teaching cum Research Fellow2003 - 2005
Education
-
University of Gothenburg Post doctoral fellow2009 - 2011
-
University of Madras - Guindy Campus Ph.D Biochemistry2005 - 2009
-
Bioinformatics Centre Pondicherry Adv. PG. Diploma in Bioinformatics2002 - 2003
-
Pondicherry University M.Sc Lifesciences2000 - 2002
-
University of Madras B.Sc1997 - 2000
Projects & Funding
Projects & funding information is unavailable.
Publications (53)
- Bridging ethnopharmacology and nanomedicine: bromelain-loaded cubosomes as a biocompatible platform for cancer therapy Save
- From angiomiRs to nanomedicine: Self-assembling lipid hybrid nanocarriers for microRNA delivery in lung cancer Save
- Targeting epigenetic regulatory machinery to overcome cervical cancer chemoresistance Save
- Fibrin-assisted nanocarrier systems: innovations and challenges in targeted carcinoma drug delivery Save
- Evaluating the stability and efficacy of fractal-fractional models in reproductive cancer apoptosis with ABT-737 Save
- Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms Save
- Decoding the Impact of Genetic Polymorphisms in Xenobiotic Metabolizing Enzymes and Ovarian Cancer: A Comprehensive Review Save
- Exploring the liposomal encapsulation and enhanced cytotoxicity of selenium nanoparticles against lung cancer cells Save
- Modulation of proteases in liver cancer by quercetin: a therapeutic perspective Save
- Microbubble-based liposomal delivery of dasatinib and COL11A1siRNA for enhanced combination therapy against lung adenocarcinoma Save